EUREGHA is pleased to announce the upcoming Final Conference of the InnoMedCatalyst project, “Turning Regional Health Innovation into European Investment”, taking place on 3 December 2026 in Brussels. The event will bring together regional authorities, innovation clusters, investors, healthcare stakeholders and policymakers to explore how regional health innovation can be translated into concrete investment opportunities and scaled across Europe.
Date: Thursday, 3 December 2026
Time: 09:30–17:00 CET
Venue: Northern Ireland Executive Office, Brussels
About the Conference
As the InnoMedCatalyst project approaches its conclusion, the Final Conference will provide an opportunity to showcase its main achievements and discuss the future of interregional cooperation in digital health innovation.
Funded under the Interregional Innovation Investments (I3) Instrument, InnoMedCatalyst has worked to strengthen regional innovation ecosystems in 5P Digital Medicine, connecting innovators, healthcare stakeholders and investors to foster collaboration, investment readiness and the scaling of innovative solutions.
The conference will explore how these efforts can contribute to stronger European innovation ecosystems, while highlighting the importance of regional cooperation and EU investment instruments in bringing health innovation closer to healthcare systems and citizens.
Conference Highlights
The programme will focus on the project’s key outcomes and their implications for future European cooperation and investment:
Joint Interregional Roadmap for 5P Digital Medicine: presenting a shared strategic vision for advancing digital health innovation across regional ecosystems.
MEDIC NEST: introducing the support structure designed to facilitate cooperation and the scaling of health innovation across regions.
Portfolio of Interregional Investment Projects: showcasing opportunities to connect innovative solutions with cross-border partnerships and investment.
Brussels Call to Action: Strengthening Clusters and Interregional Innovation: presenting joint policy recommendations advocating for the continuation and strengthening of the I3 Instrument within the 2028–2034 EU Multiannual Financial Framework, supporting cluster-led cooperation, regional capacity-building and cross-border innovation investments.
The final programme and speakers are subject to confirmation.
Why attend?
The conference will offer an opportunity to:
Discover the main results of InnoMedCatalyst and their potential contribution to European digital health innovation.
Explore how regional ecosystems can collaborate to develop and scale innovative healthcare solutions.
Connect with regional authorities, clusters, innovators, investors and policymakers working across European health innovation ecosystems.
Contribute to discussions on the future of interregional innovation investments and the role of EU funding in strengthening regional capacities.
posts navigation
related posts
